MCT-BASED NUTRITION BLEND FOR PROVIDING HEALTH BENEFITS IN COMPANION ANIMALS
A method for reducing blood pressure or treating renal or kidney disease in a companion animal, the method comprising orally administering a composition comprising a therapeutically effective amount of medium chain triglycerides to the companion animal.
1 . A method for reducing blood pressure in a companion animal, the method comprising orally administering a composition comprising a therapeutically effective amount of medium chain triglycerides to the companion animal.
2 . The method of claim 1 , wherein the composition further comprises a component selected from the group consisting of an omega-3 fatty acid, Vitamin E, magnesium, taurine, lysine, a sulfur-containing amino acid, and mixtures thereof.
3 . The method of claim 2 , wherein the omega-3 fatty acid is selected from the group consisting of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and mixtures thereof.
4 . The method of claim 2 , wherein the sulfur-containing amino acid is selected from the group consisting of methionine, cysteine, homocysteine, taurine and mixtures thereof.
5 . The method of claim 1 , wherein the composition is a complete and nutritionally balanced pet food.
6 . The method of claim 1 , wherein the medium chain triglycerides are about 0.5 wt % to about 60 wt % of the composition.
7 . The method of claim 1 , wherein the medium chain triglycerides include a medium-chain fatty acid selected from the group consisting of caprylic acid, capric acid, and a mixture thereof.
8 . The method of claim 1 , wherein the composition further comprises a component selected from the group consisting of carnitine, lysine and methionine, glutathione, and a mixture thereof.
9 . The method of claim 1 , wherein the composition has a characteristic selected from the group consisting of (i) ratio of potassium to sodium from about 5:1 to about 1:1, (ii) magnesium in an amount from about 0.08 wt % to about 0.25 wt %, (iii) protein in an amount of at least 20 wt %, and (iv) combinations thereof.
10 . The method of claim 1 , wherein the composition is administered to the companion animal daily for at least one week.
11 . The method of claim 1 , wherein the composition is administered in an amount that provides about 0.001 g to about 50.0 g of the MCTs per kg body weight of the companion animal per day.
12 . The method of claim 1 , wherein reducing blood pressure provides a renal or kidney benefit.
13 . The method of claim 1 , wherein the companion animal is a canine.
14 . A method of treating kidney or renal disease or a condition relating thereto in a companion animal in need thereof, the method comprising orally administering a composition comprising a therapeutically effective amount of medium chain triglycerides to the companion animal.
15 . The method of claim 14 , wherein the medium chain triglycerides are about 0.5 wt % to about 60 wt % of the composition.
16 . The method of claim 14 , wherein the composition further comprises a component selected from the group consisting of an omega-3 fatty acid, Vitamin E, magnesium, taurine, lysine, a sulfur-containing amino acid, and mixtures thereof.
17 . The method of claim 14 , wherein the composition has a characteristic selected from the group consisting of (i) ratio of potassium to sodium from about 5:1 to about 1:1, (ii) magnesium in an amount from about 0.08 wt % to about 0.25 wt %, (iii) protein in an amount of at least 20 wt %, and (iv) combinations thereof.
18 . The method of claim 14 , wherein the companion animal is a canine.
19 . The method of claim 14 , wherein the condition is elevated blood pressure.